{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:05:26Z","timestamp":1792004726302,"version":"4.4.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.xops.2026.101190","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T23:25:03Z","timestamp":1776295503000},"page":"101190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fluid Volumes Longitudinal Modeling to Predict Atrophy and Fibrosis in Neovascular Age-Related Macular Degeneration"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9374-3708","authenticated-orcid":false,"given":"Stefano","family":"Mercuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Sacu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Frank-Publig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Schrittwieser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Gumpinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Leingang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Schmidt-Erfurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Chakravarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrvoje","family":"Bogunovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Virgili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor S.","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2026.101190_bib1","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/s41433-019-0393-3","article-title":"Socio-economic status and outcomes for patients with age-related macular degeneration","volume":"33","author":"More","year":"2019","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2026.101190_bib2","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/j.ophtha.2020.01.033","article-title":"Prevalence of age-related maculopathy: the Beaver Dam Eye Study","volume":"127","author":"Klein","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101190_bib3","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/jamaophthalmol.2024.4401","article-title":"Economic burden of late-stage age-related macular degeneration in Bulgaria, Germany, and the US","volume":"142","author":"Paudel","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2026.101190_bib4","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.xops.2026.101190_bib5","article-title":"Anti-vascular endothelial growth factor for neovascular agerelated macular degeneration","volume":"3","author":"Solomon","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.xops.2026.101190_bib6","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.ophtha.2016.04.056","article-title":"Anti\u2013vascular endothelial growth factor agents in the treatment of retinal disease: from bench to bedside","volume":"123","author":"Campochiaro","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101190_bib7","first-page":"860","article-title":"Treatment regimens for optimising outcomes in patients with neovascular age-related macular degeneration","volume":"39","author":"Teo","year":"2025","journal-title":"Eye (Basingstoke)"},{"key":"10.1016\/j.xops.2026.101190_bib8","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1038\/s41433-022-02153-9","article-title":"15 years of anti-VEGF treatment for nAMD: success or failure or something in between?","volume":"36","author":"Chakravarthy","year":"2022","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2026.101190_bib9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ajo.2023.03.033","article-title":"Ten-year incidence of fibrosis and risk factors for its development in neovascular age-related macular degeneration","volume":"252","author":"Romano","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101190_bib10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1167\/iovs.65.1.44","article-title":"Relationship of topographic distribution of macular atrophy secondary to neovascular AMD and reading performance","volume":"65","author":"Ricardi","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2026.101190_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/iovs.65.3.18","article-title":"Distinct pathways of macular atrophy in type 3 macular neovascularization associated with AMD","volume":"65","author":"Borrelli","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2026.101190_bib12","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00417-013-2562-6","article-title":"Efficacy of treatment with ranibizumab in patients with wet age-related macular degeneration in routine clinical care: data from the COMPASS health services research","volume":"252","author":"Wolf","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.xops.2026.101190_bib13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/jop.2017.0031","article-title":"Real-life experience with aflibercept and ranibizumab in the treatment of newly diagnosed neovascular age-related macular degeneration over 24 months","volume":"33","author":"Garweg","year":"2017","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.xops.2026.101190_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajoint.2025.100124","article-title":"Evidence for whom? A systematic review of eligibility criteria in RCTs of anti-VEGF for neovascular age-related macular degeneration","volume":"2","author":"Arnold-Vangsted","year":"2025","journal-title":"AJO Int"},{"key":"10.1016\/j.xops.2026.101190_bib15","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1038\/s41433-024-03308-6","article-title":"Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era","volume":"38","author":"Armendariz","year":"2024","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2026.101190_bib16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.survophthal.2023.03.004","article-title":"Fibrosis in neovascular age-related macular degeneration: a review of definitions based on clinical imaging","volume":"68","author":"Bachmeier","year":"2023","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.xops.2026.101190_bib17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajo.2022.09.008","article-title":"Review of fibrosis in neovascular age-related macular degeneration","volume":"246","author":"Cheong","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101190_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1167\/iovs.63.6.17","article-title":"The association of fluid volatility with subretinal hyperreflective material and ellipsoid zone integrity in neovascular AMD","volume":"63","author":"Ehlers","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2026.101190_bib19","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.oret.2018.04.009","article-title":"Atrophy in neovascular age-related macular degeneration: age-related eye disease study 2 report number 15","volume":"2","author":"Domalpally","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2026.101190_bib20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.oret.2025.01.011","article-title":"Macular atrophy in neovascular age-related macular degeneration: a systematic review and meta-analysis","volume":"9","author":"Berni","year":"2025","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2026.101190_bib21","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/s41433-025-03723-3","article-title":"Long-term macular atrophy growth in neovascular age-related macular degeneration: influential factors and role of genetic variants","volume":"39","author":"Vofo","year":"2025","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2026.101190_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/VLFL1739","article-title":"Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study","volume":"26","author":"Banister","year":"2022","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.xops.2026.101190_bib23","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.oret.2020.01.012","article-title":"Progression from early\/intermediate to advanced forms of age-related macular degeneration in a large UK cohort: rates and risk factors","volume":"4","author":"Chakravarthy","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2026.101190_bib24","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1038\/s41433-020-01354-4","article-title":"Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD","volume":"35","author":"Chakravarthy","year":"2021","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2026.101190_bib25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ophtha.2018.11.025","article-title":"Tolerating subretinal fluid in neovascular age-related macular degeneration treated with ranibizumab using a treat-and-extend regimen: FLUID study 24-month results","volume":"126","author":"Guymer","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101190_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e31567","article-title":"Dynamics and patterns of recurrence in neovascular AMD during real-world management using automated fluid monitoring","volume":"10","author":"Prenner","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.xops.2026.101190_bib27","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1097\/IAE.0000000000003557","article-title":"Validation of an automated fluid algorithm on real-world data of neovascular age-related macular degeneration over five years","volume":"42","author":"Gerendas","year":"2022","journal-title":"Retina"},{"key":"10.1016\/j.xops.2026.101190_bib28","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jcjo.2023.10.017","article-title":"Long-term effect of fluid volumes during the maintenance phase in neovascular age-related macular degeneration: results from Fight Retinal Blindness","volume":"59","author":"Reiter","year":"2024","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101190_bib29","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1097\/IAE.0000000000003180","article-title":"Impact of residual subretinal fluid volumes on treatment outcomes in a subretinal fluid-tolerant treat-and-extend regimen","volume":"41","author":"Grechenig","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.xops.2026.101190_bib30","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/IAE.0000000000003023","article-title":"Analysis of fluid volume and its impact on visual acuity in the fluid study as quantified with deep learning","volume":"41","author":"Reiter","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.xops.2026.101190_bib31","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41433-024-03460-z","article-title":"Artificial intelligence in assessing progression of age-related macular degeneration","volume":"39","author":"Frank-Publig","year":"2025","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2026.101190_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s41512-020-00078-z","article-title":"Harnessing repeated measurements of predictor variables for clinical risk prediction: a review of existing methods","volume":"4","author":"Bull","year":"2020","journal-title":"Diagn Progn Res"},{"key":"10.1016\/j.xops.2026.101190_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12874-023-01845-4","article-title":"Multivariate longitudinal data for survival analysis of cardiovascular event prediction in young adults: insights from a comparative explainable study","volume":"23","author":"Nguyen","year":"2023","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.xops.2026.101190_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e10932","article-title":"Modeling strategies to analyse longitudinal biomarker data: an illustration on predicting immunotherapy non-response in non-small cell lung cancer","volume":"8","author":"van Delft","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.xops.2026.101190_bib35","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ophtha.2017.10.031","article-title":"Fully automated detection and quantification of macular fluid in OCT using deep learning","volume":"125","author":"Schlegl","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101190_bib36","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.ophtha.2020.03.010","article-title":"Application of automated quantification of fluid volumes to anti\u2013VEGF therapy of neovascular age-related macular degeneration","volume":"127","author":"Schmidt-Erfurth","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101190_bib37","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.survophthal.2023.10.013","article-title":"Subretinal hyperreflective material in retinal and chorioretinal disorders: a comprehensive review","volume":"69","author":"Feo","year":"2024","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.xops.2026.101190_bib38","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1167\/iovs.18-25189","article-title":"Identification and quantification of the angiofibrotic switch in neovascular AMD","volume":"60","author":"Roberts","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2026.101190_bib39","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","article-title":"Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101190_bib40","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1080\/01621459.1989.10478874","article-title":"The robust inference for the cox proportional hazards model","volume":"84","author":"Lin","year":"1989","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.xops.2026.101190_bib41","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/aos.17458","article-title":"Comparison of AI-based retinal fluid monitoring in neovascular age-related macular degeneration with manual assessment by different eye care professionals under optimized conditions","volume":"103","author":"Michl","year":"2025","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.xops.2026.101190_bib42","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajo.2020.12.012","article-title":"e al. Automated quantitative assessment of retinal fluid volumes as important biomarkers in neovascular age-related macular degeneration","volume":"224","author":"Keenan","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101190_bib43","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1111\/aos.14905","article-title":"The role of retinal fluid location in atrophy and fibrosis evolution of patients with neovascular age-related macular degeneration long-term treated in real world","volume":"100","author":"Llorente-Gonz\u00e1lez","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.xops.2026.101190_bib44","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/IAE.0000000000000902","article-title":"Implication of recurrent or retained fluid on optical coherence tomography for visual acuity during active treatment of neovascular age-related macular degeneration with a treat and extend protocol","volume":"36","author":"Wickremasinghe","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.xops.2026.101190_bib45","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ophtha.2018.08.035","article-title":"Macular morphology and visual acuity in year five of the comparison of age-related macular degeneration treatments trials","volume":"126","author":"Jaffe","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101190_bib46","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ophtha.2017.12.026","article-title":"Macular atrophy in the HARBOR study for neovascular age-related macular degeneration","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101190_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12886-021-02063-6","article-title":"Analyses of the effects of persistent subretinal fluid on visual\/anatomic outcomes according to the type of macular neovascularization during the relaxed treat-and-extend protocol in age-related macular degeneration patients","volume":"21","author":"Kim","year":"2021","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.xops.2026.101190_bib48","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jamaophthalmol.2022.1357","article-title":"Association between visual acuity and residual retinal fluid following intravitreal anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration: a systematic review and meta-analysis","volume":"140","author":"Patil","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2026.101190_bib49","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1136\/bjophthalmol-2020-318688","article-title":"Anti-VEGF-resistant subretinal fluid is associated with better vision and reduced risk of macular atrophy","volume":"106","author":"Zarbin","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101190_bib50","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/IAE.0000000000000465","article-title":"Refractory intraretinal or subretinal fluid in neovascular age-related macular degeneration treated with intravitreal ranizubimab: functional and structural outcome","volume":"35","author":"Gianniou","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.xops.2026.101190_bib51","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1038\/s41433-020-0799-y","article-title":"Association between visual acuity, lesion activity markers and retreatment decisions in neovascular age-related macular degeneration","volume":"34","author":"Chakravarthy","year":"2020","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2026.101190_bib52","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ophtha.2020.09.025","article-title":"Quantitative analysis of OCT for neovascular age-related macular degeneration using deep learning","volume":"128","author":"Moraes","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101190_bib53","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.oret.2021.02.012","article-title":"Longitudinal assessment of ellipsoid zone integrity, subretinal hyperreflective material, and subretinal pigment epithelium disease in neovascular age-related macular degeneration","volume":"5","author":"Ehlers","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2026.101190_bib54","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajo.2020.11.002","article-title":"Localized optical coherence tomography precursors of macular atrophy and fibrotic scar in the comparison of age-related macular degeneration treatments trials","volume":"223","author":"Finn","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101190_bib55","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.oret.2019.06.002","article-title":"The evolution of fibrosis and atrophy and their relationship with visual outcomes in Asian persons with neovascular age-related macular degeneration","volume":"3","author":"Cheung","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2026.101190_bib56","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.ophtha.2018.01.004","article-title":"Development and course of scars in the comparison of age-related macular degeneration treatments trials","volume":"125","author":"Daniel","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101190_bib57","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1038\/s41433-023-02507-x","article-title":"Visual acuity time in range: a novel concept to describe consistency in treatment response in diabetic macular oedema","volume":"37","author":"Kozak","year":"2023","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2026.101190_bib58","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1167\/tvst.14.5.23","article-title":"Area under the curve analysis in a real-world cohort of finnish patients treated for neovascular age-related macular degeneration","volume":"14","author":"Ollila","year":"2025","journal-title":"Transl Vis Sci Technol"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526001284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526001284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:33:19Z","timestamp":1782948799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914526001284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2666914526001284"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2026.101190","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluid Volumes Longitudinal Modeling to Predict Atrophy and Fibrosis in Neovascular Age-Related Macular Degeneration","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2026.101190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101190"}}